Genetic Inflammatory Factors Predict Restenosis After Percutaneous Coronary Interventions
Author(s) -
Pascalle S. Monraats,
Nuno Pires,
Willem R.P. Agema,
Aeilko H. Zwinderman,
Abbey Schepers,
Moniek P.M. de Maat,
Pieter A. Doevendans,
Robbert J. de Winter,
René A. Tio,
Johannes Waltenberger,
Rune R. Frants,
Paul H.A. Quax,
Bart J.M. van Vlijmen,
Douwe E. Atsma,
Arnoud van der Laarse,
Ernst E. van der Wall,
J. Wouter Jukema
Publication year - 2005
Publication title -
circulation
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 7.795
H-Index - 607
eISSN - 1524-4539
pISSN - 0009-7322
DOI - 10.1161/circulationaha.105.536268
Subject(s) - medicine , restenosis , conventional pci , percutaneous coronary intervention , prospective cohort study , cardiology , bioinformatics , myocardial infarction , biology , stent
Restenosis is a negative effect of percutaneous coronary intervention (PCI). No clinical factors are available that allow good risk stratification. However, evidence exists that genetic factors are important in the restenotic process as well as in the process of inflammation, a pivotal factor in restenosis. Association studies have identified genes that may predispose to restenosis, but confirmation by large prospective studies is lacking. Our aim was to identify polymorphisms and haplotypes in genes involved in inflammatory pathways that predispose to restenosis.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom